Company / Total Assets
Bionano Genomics, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$73.6M
FY2025
5-year range
$73.6M / $377.1M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $377M in FY2021 to $74M in FY2025.
Based on SEC 10-K filings.
$74M in FY2025 with a 5-year CAGR of +4.0%.
Declined from $214M to $74M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -37.9%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Bionano Genomics, Inc.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, total assets decreased 4.0% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.6M | -4.0% |
| FY2024 | $76.7M | -64.2% |
| FY2023 | $214.4M | -30.3% |
| FY2022 | $307.5M | -18.5% |
| FY2021 | $377.1M | +523.8% |
| FY2020 | $60.5M | +100.1% |
| FY2019 | $30.2M | +21.8% |
| FY2018 | $24.8M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026